The Compound Annual Growth Rate (CAGR) of the Ovarian Cysts market is expected to be booming at 8.2% during the forecast period 2017-2023, as revealed by the Market Research Future (MRFR) report. The MRFR is a leading publisher of business market research report.
The ovarian cysts are closed, fluid-filled sacs present within the ovary. Occasionally the ovarian cysts may lead to bloating, lower abdominal pain and lower back pain. The formation of the ovarian cysts in ovulation females is a common thing. But, if the ovarian cysts are formed after the menopause in females, then there is a big chance that they may suffer from ovarian cancer. So, the increase in prevalence of ovarian cysts is expected to boost the ovarian cyst market during the year 2017-2023.
In 2017, a study was published in the Journal of Clinical Research in Pediatric Endocrinology where it was revealed that the frequency of ovarian is nearly 1.8 % in children that are aged between 5-9 years and is about 18.8% in children aged between 10-18 years. The study also revealed that when the females reach adolescence and further, the frequency of ovarian cysts in them increase and ranges in-between 3.8 %-31.3%.
As per the MRFR report, increasing ovarian cancer patients, rising health care expenditures and surge in awareness about woman health are expected to boost the global ovarian cysts market growth. Being said that, the MRFR has also revealed that the market growth can be affected due to the low per capita healthcare expenditure and lack of awareness in the developing countries. The global ovarian cysts market is divided on the basis of four criteria- type, diagnosis, treatment and end users.
Based on the type, the market is divided into functional cysts, non-functional cysts, and others. The functional cysts type is again segmented into corpus luteum cyst, follicular cyst and others whereas the non-functional cyst type is divided into cystadenomas, dermoid cysts, endometriomas and others. Then, on the basis of diagnosis, the ovarian cysts market is divided into imaging, laparoscopy, CA-125 blood test and others. Also, the imaging is subdivided into MRI, CT scan, ultrasound and others. Based on treatment, the market is segmented into polycystic ovary syndrome (PCOS) drugs, pain relievers, medication, surgery and others. Lastly, on the basis of end users, the market is divided into medical institutes, hospitals and clinics, research organizations and others.